Catalog #: L-008A
Size: 88 peptides
Price: $6,137
Phoenix Pharmaceuticals’ Anti-Angiogenic Peptide Library is a collection of 88 peptides designed to inhibit angiogenesis, the formation of new blood vessels. Our Anti-Angiogenic Peptide Library is used in research to identify peptides that can block blood vessel growth, which can be relevant in various applications like cancer treatment, wound healing, and vascular diseases.
| # | Catalog # | Product Name | M.W. |
|---|---|---|---|
| 1 | 019-55 | Tetrastatin-1 | 2352.79 |
| 2 | 019-57 | Pentastatin-3 | 2090.29 |
| 3 | 019-56 | Tetrastatin-3 | 2090.31 |
| 4 | 019-58 | Thrombostatin con-3 | 2080.31 |
| 5 | 019-59 | Chemokinostatin-7 | 2535.09 |
| 6 | 019-60 | Chemokinostatin-8 | 2802.25 |
| 7 | 019-61 | Semastatin-5A.1 | 2102.39 |
| 8 | 019-62 | Semastatin-5B | 2041.21 |
| 9 | 019-63 | Properdistatin | 2177.50 |
| 10 | 019-64 | Scospondistatin | 2023.19 |
| 11 | 019-65 | Chemokinostatin-1 | 2625.20 |
| 12 | 019-66 | Chemokinostatin-3 | 2395.96 |
| 13 | 019-67 | Chemokinostatin-5 | 2612.13 |
| 14 | 019-68 | Chemokinastatin-6 | 2684.20 |
| 15 | 019-69 | Semastatin-5A.2 | 2099.40 |
| 16 | 019-70 | Nephroblastostatin | 1951.24 |
| 17 | 019-71 | Wispostatin-1 | 1838.10 |
| 18 | 019-72 | Thrombostatin con-1 | 2192.43 |
| 19 | 019-73 | Netrinstatin-5C | 2287.57 |
| 20 | 019-74 | Thrombostatin con-6, cyclic | 1884.13 |
| 21 | 019-75 | Wispostatin-2 | 1812.13 |
| 22 | 019-76 | Wispostatin-3 | 1997.35 |
| 23 | 019-77 | Papilostatin-1 | 1694.83 |
| 24 | 019-78 | Papilostatin-2 | 2100.33 |
| 25 | 019-79 | Hexastatin-2 | 2547.86 |
| 26 | 019-80 | Spondinstatin-1 | 2187.47 |
| 27 | 019-81 | Connectostatin | 1917.22 |
| 28 | 019-82 | Cyrostatin | 1902.14 |
| 29 | 019-83 | Netrinstatin-5D | 2280.58 |
| 30 | 019-84 | Fibulostatin-6.1 | 2094.45 |
| 31 | 019-85 | Fibulostatin-6.2 | 1940.16 |
| 32 | 019-86 | Fibulostatin-6.3 | 2053.27 |
| 33 | 019-87 | Cartilostatin-1 | 2124.39 |
| 34 | 019-88 | Cartilostatin-2 | 2055.38 |
| 35 | 019-89 | Adamtsostatin-4 | 1957.14 |
| 36 | 019-90 | Adamtsostatin-16 | 1724.90 |
| 37 | 019-91 | Adamtsostatin-18 | 2145.41 |
| 38 | 019-92 | Adamtsostatin-Like 4 | 2333.65 |
| 39 | 019-93 | Complestatin-C6 | 2168.36 |
| 40 | 019-94 | Tetrastatin-2 | 2569.87 |
| 41 | 019-95 | Hexastatin-3 | 2447.89 |
| 42 | 053-35 | Vasostatin I (17-76) (Human) | 6811.83 |
| 43 | 053-34 | Vasostatin I (17-43) (Human) | 3009.52 |
| 44 | 053-33 | Vasostatin I / prepro-Chromogranin A (19-94) (Human) | 8553.90 |
| 45 | 053-32 | VIF / Vasostatin II, C-terminal / prepro-Chromogranin A (97-131) (Human) | 3908.13 |
| 46 | 026-81 | Fractalkine (CX3CL1) Chemokine Domain (1-80) / Fractalkine precursor (25-104) (Human) | 9053.82 |
| 47 | 047-95 | Secretoneurin (Rat) | 3652.01 |
| 48 | 070-41 | Thymosin beta4 | 4963.55 |
| 49 | 030-30 | Amphiregulin, C-terminal (Human) | 4794.38 |
| 50 | 035-62 | Relaxin 2 (Human) | 5963.06 |
| 51 | 090-01 | Endostatin (52-114) amide / JKC362 (Human) | 6985.00 |
| 52 | 007-25 | ELA-32 (Human) | 3967.87 |
| 53 | 016-50 | T3 Peptide / Tumstatin (69-88) (Human) | 2407-85 |
| 54 | 016-51 | T7 Peptide / Tumstatin (74-98) (Human) | 3018.83 |
| 55 | 057-18 | Apelin-13 (Human, Rat, Mouse, Bovine) | 1550.85 |
| 56 | 057-36 | SCNH2 / Selecting Cutting Apelin-36 (1-16) amide (Human) | 1704.91 |
| 57 | 051-15 | Angiopoietin-Like 3 (ANGPTL 3) (140-220) (Human) | 9519.95 |
| 58 | 051-20 | Angiopoietin-Like 4 (ANGPTL 4) (97-160) (Human) | 7555.66 |
| 59 | 019-41 | UN-1 / Thrombin Preproprotein (354-363) (Human) | 1193.29 |
| 60 | 019-42 | UN-2 / Thrombin Preproprotein (315-327) (Human) | 1560.67 |
| 61 | 019-43 | UN-3 (Human) | 2834.08 |
| 62 | 030-21 | hSDF-1 alpha, synthetic (Human) | 7606.01 |
| 63 | 012-52 | PEDF-34 / prepro-PEDF (44-77) (Human) | 3763.26 |
| 64 | 012-54 | PEDF-43 / prepro-PEDF (79-121) (Human) | 4582.58 |
| 65 | 012-53 | PEDF-44 / prepro-PEDF (78-121) / P78 (Human) | 4680.25 |
| 66 | 048-09 | Neurotensin (8-13) (Human, Rat, Mouse) | 816.51 |
| 67 | 048-10 | acetyl-Neurotensin (8-13) (Human, Rat, Mouse) | 858.55 |
| 68 | 075-09 | PR-39 | 4720.73 |
| 69 | 057-07 | Cyclo(1-6)CRPRLC-KH-Cyclo(9-14)CRPRLC | 1737.41 |
| 70 | 057-08 | MM07 / Cyclo (1-6) APJ agonist | 1539.91 |
| 71 | 090-03 | Endostatin (133-180) amide / Endostatin Derived E4 (Human) | 5116.75 |
| 72 | 031-30 | Ghrelin (Human) | 3371.92 |
| 73 | 075-06 | LL37 (Human) | 4493.36 |
| 74 | 072-48 | Defensin 2, beta, synthetic (Human) | 4328.27 |
| 75 | 045-66 | CXCL4 / Platelet Factor 4 (PF-4) (47-70) (Human) | 2785.44 |
| 76 | 045-67 | CXCL4L1 / Platelet Factor 4 (PF-4) Var (47-70) (Human) | 2846.42 |
| 77 | 072-12 | WKYMVm | 856.11 |
| 78 | 075-35 | Vasotide | 588.76 |
| 79 | 065-50 | pro-Vasopressin (152-166) / Hypothalamic PRP-1 (Bovine, Porcine) | 1453.55 |
| 80 | 012-21 | prepro-Augurin (42-65) (Human) | 2571.95 |
| 81 | 025-74 | NGR Peptide 1 | 2168.70 |
| 82 | 025-55 | [Lys1015, Lys1024]-Thrombospondin-1 (1015-1024) / 4KN1 (Human, Mouse, Bovine) | 1384.77 |
| 83 | 012-55 | PEDF (388-394) (Human) | 918.02 |
| 84 | 007-57 | VEGF (125-136) (Human) | 1592.89 |
| 85 | 007-58 | VEGFR binding peptide KH / QKRKRKKSRKKH | 1607.95 |
| 86 | 007-59 | VEGFR binding peptide IVLS / RKRKRKKSRYIVLS | 1818.22 |
| 87 | 007-56 | Apolipoprotein A (4291-4301) / KV11 (Human) | 1447.66 |
| 88 | 030-25 | Peptide R / CXCR4 Antagonist | 900.10 |
No results found.
